Department of Internal Medicine

Research output

Research output per year 2014 2019 2020 2021 2022 2023 2024 2025

• 377 Journal article
• 59 Review article
• 28 Conference contribution to journal
• 24 Poster at a conference
• 84 More
  • 22 Oral presentation at a conference
  • 17 Editorial
  • 13 Case report
  • 11 Letter/short communication
  • 9 Other publication (not peer-reviewed)
  • 4 Contribution to conference proceeding
  • 3 Chapter in book/report
  • 3 Invited talk/keynote at a conference
  • 2 Book

Research output per year

Research output per year

Search results

• 2024

  Assessing Healthcare Providers' Knowledge and Care Regarding Cardiovascular Risk of Women Diagnosed with Hypertensive Disorders of Pregnancy and Gestational Diabetes Mellitus

  Fohleitner, S., Jutz, F., Busvine, C., Halmer, S., Wichert-Schmitt, B., Schubert, S. & Pfaller-Eiwegger, B., 02 Sept 2024, In: Geburtshilfe und Frauenheilkunde.

  Research output: Journal article (peer-reviewed) › Conference contribution to journal
• 2023

  Abstract 15319: Impact of Atherosclerotic Cardiovascular Disease Risk Factors on Pregnancy Outcomes in Women With Heart Disease

  Fernandez campos, B. A., Grewal, J., Kiess, M. C., Pfaller-Eiwegger, B., Massarella, D., Siu, S. C. & Silversides, C., 07 Nov 2023, In: Circulation. 148, Suppl_1

  Research output: Journal article (peer-reviewed) › Conference contribution to journal

• Association of aortic valve size with the degree of aortic valve calcification in patients with severe aortic stenosis

  Mousavi, R. A., Lamm, G., Will, M., Hoebart, P., Kammerlander, A. A., Schwarz, K., Vock, P., Hoppe, U. & Mascherbauer, J., 09 Nov 2023, In: European Heart Journal. 44, Supplement_2

  Research output: Journal article (peer-reviewed) › Conference contribution to journal

• Impact of Immune Checkpoint Inhibitors on Bone Turnover in Cancer Patients: in Vitro Studies and Clinical Correlate

  Gassner, T., Chittilappilly, C., Pirich, T., Lind, J., Hackner, K., Zwickl-Traxler, E., Errhalt, P., Pecherstorfer, M., Podar, K. & Vallet, S., 10 Mar 2023, In: Memo - Magazine of European Medical Oncology. 16 , Abstracts OeGHO / AHOP, O16.

  Research output: Journal article (peer-reviewed) › Conference contribution to journal

  Open Access
• 2022

  1255 Impact of immune checkpoint inhibitors on bone turnover in cancer patients: prospective clinical study and preclinical correlates

  Gassner, T., Vallet, S., Chittilappilly, C., Pirich, T., Lind, J., Aksoy, O., Sunder-Plassmann, V., Hackner, K., Zwickl-Traxler, E., Errhalt, P., Pecherstorfer, M. & Podar, K., 2022, In: Journal for ImmunoTherapy of Cancer. p. A1300-A1300

  Research output: Journal article (peer-reviewed) › Conference contribution to journal

  Open Access

• 23P Enriching for response: Patient selection criteria for A2AR inhibition by EXS-21546 through ex vivo modelling in primary patient material

  Vladimer, G., Alt, I., Sehlke, R., Lobley, A., Baumgärtler, C., Stulic, M., Hackner, K., Dzurillova, L., Petru, E., Hadjari, L., Lafleur, J., Singer, J., Krall, N., Šufliarsky, J., Hefler, L., Fuereder, T., Taubert, C., Boudesco, C. & Payne, A., 01 Dec 2022, In: Immuno-Oncology and Technology. 16, p. 100128

  Research output: Journal article (peer-reviewed) › Conference contribution to journal

  Open Access

• Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension improves sleep-disordered breathing

  Hackner, K., Gerges, C., Bauer, S., Kneussl, M., Errhalt, P., Javaheri, S. & Lang, I. M., Dec 2022, In: European Respiratory Journal. p. 331

  Research output: Journal article (peer-reviewed) › Conference contribution to journal

  Open Access

• Defining activity and patient selection of a novel CDK7 inhibitor, GTAEXS-617, through AI-supported primary cancer tissue profiling

  Somlyay, M., Durinikova, E., Besnard, J., Barbeau, O., Le Coz, J., Senekowitsch, M., Ergüner, B., Hackner, K., Dzurillova, L., Petru, E., Lafleur, J., Singer, J., Füreder, T., Paveley, R., Joseph, J., Aswad, F., Winkler-Penz, T., Sehlke, R., Boudesco, C. & Vladimer, G., Oct 2022, In: European Journal of Cancer. 174, p. S44-S45

  Research output: Journal article (peer-reviewed) › Conference contribution to journal

  Open Access

• Die Auswirkung von Osteoblasten und deren Präkursoren auf das Schicksal von Brustkrebszellen: Abstracts

  Lind, J., Gassner, T., Aksoy, O., Sunder-Plaßmann, V., Pecherstorfer, M., Podar, K. & Vallet, S., 27 Sept 2022, In: Oncology Research and Treatment. 45, Suppl. 2, p. 5-346 342 p., P360.

  Research output: Journal article (peer-reviewed) › Conference contribution to journal

  Open Access
  2 Citations (Scopus)

• Effects of immune checkpoint-inhibitors on bone turnover in cancer patients

  Pirich, T., Hackner, K., Zwickl-Traxler, E., Gassner, T., Errhalt, P., Pecherstorfer, M., Podar, K. & Vallet, S., 08 Mar 2022, In: Memo - Magazine of European Medical Oncology. 15 | Abstracts OeGHO / AHOP, Supplement 3/22, O05.

  Research output: Journal article (peer-reviewed) › Conference contribution to journal

  Open Access

• P-24 Gender differences in overall survival in patients with metastatic pancreatic cancer

  Taghizadeh, H. & Wiesholzer, M., 01 Jun 2022, In: Annals of Oncology. 33, p. S255

  Research output: Journal article (peer-reviewed) › Conference contribution to journal

  Open Access

• P-283: TRIATLON - triple class exposed/refractory multipLe myeloma patients: a real world analysis (RWA) from the Austrian Myeloma Registry (AMR)

  Willenbacher, E., Pichler, P., Strassl, I., Krauth, M., Agis, H., Sormann, S., Hartmann, B., Podar, K., Weger, R. & Willenbacher, W., 01 Aug 2022, In: Clinical Lymphoma, Myeloma and Leukemia. 22, p. S193-S194

  Research output: Journal article (peer-reviewed) › Conference contribution to journal

• S179: RANDOMIZED COMPARISON BETWEEN KRD AND KTD INDUCTION, FOLLOWED BY K MAINTENANCE OR OBSERVATION IN TRANSPLANT NON-ELIGIBLE PATIENTS WITH NDMM (AGMT-MM02 TRIAL)

  Ludwig, H., Melchardt, T., Sormann, S., Zojer, N., Andel, J., Hartmann, B., Tinchon, C., Gunsilius, E., Podar, K., Egle, A., Willenbacher, W., Wöll, E., Schreder, M., Ruckser, R., Bozic, B., Krauth, M. T., Petzer, A., Schmitt, C., Machherndl-Spandl, S. & Agis, H. & 5 others, Fillitz, M., Pönisch, W., Knop, S., Paiva, B. & Greil, R., 2022, In: HemaSphere. 6, p. 80-81

  Research output: Journal article (peer-reviewed) › Conference contribution to journal

  Open Access

• Verzögerte Intervallgeburt einer Zwillingsschwangerschaft nach Eizellspende im Alter von 55 Jahren

  Schubert, S., Dietl, S., Pfaller-Eiwegger, B. & Lösch, A., 10 Jun 2022, In: Geburtshilfe und Frauenheilkunde.

  Research output: Journal article (peer-reviewed) › Conference contribution to journal

  Open Access

• Women’s knowledge and care concerning long-term cardiovascular risk after hypertensive disorders of pregnancy and gestational diabetes

  Busvine, C., Rosenauer, A., Schenzel, A., Aringer, I., Fournier, C., Loesch, A., Schubert, S., Wiesholzer, M. F. & Pfaller, B., Oct 2022, In: Journal für Hypertonie.

  Research output: Journal article (peer-reviewed) › Conference contribution to journal
• 2021

  Combined targeting of distinct c-Myc and JunB transcriptional programs for multiple myeloma therapy – Update: OeGHO Frühjahrstagung, 8.-10.4.2021, Online

  Lind, J., Czernilofsky, F., Vallet, S., Fan, F., Bakiri, L., Wagner, E. F., Sattler, M., Pecherstorfer, M. & Podar, K., 2021, In: Memo - Magazine of European Medical Oncology. 14, Suppl. 2, p. 23-41 19 p.

  Research output: Journal article (peer-reviewed) › Conference contribution to journal

  Open Access

• OAB-030: Combined targeting of distinct c-Myc and JunB transcriptional programs induces synergistic anti-myeloma activity: 18th International Myeloma Workshop, 08.-11.09.2021, Vienna, Austria

  Lind, J., Vallet, S., Kollmann, K., Aksoy, O., Sunder-Plassmann, V., Zwickl-Traxler, E., Fan, F., Stoiber-Sakaguchi, D., Bakiri, L., Wagner, E., Sattler, M., Pecherstorfer, M. & Podar, K., 2021, In: Clinical Lymphoma, Myeloma and Leukemia. 21, p. S19-S20

  Research output: Journal article (peer-reviewed) › Conference contribution to journal

  • Oncogene C Myc 100%
  • Trametinib 100%
  • Transcription Factors 75%
  • Protein Catabolism 50%
  • Cell Proliferation 50%

• P-082: Delineating CDK9- regulated molecular events for the development of rationally derived multiple myeloma treatment strategies: 18th International Myeloma Workshop, 08.-11.09.2021, Vienna, Austria

  Aksoy, O., Lind, J., Sunder-Plassmann, V., Pecherstorfer, M., Vallet, S. & Podar, K., 2021, In: Clinical Lymphoma, Myeloma and Leukemia. 21, p. S83-S84

  Research output: Journal article (peer-reviewed) › Conference contribution to journal

  • RNA 100%
  • Mdm2 100%
  • IRF4 100%
  • Small Interfering RNA 66%
  • Cell Survival 66%
• 2020

  Abstract 5233: Towards patient-centric drug discovery: Analyzing drug action in malignant pleural effusions and ascites using high content imaging and deep learning: AACR Annual Meeting 2020, April 27-28, 2020 and June 22-24, Philadelphia, PA

  Sehlke, R., Taubert, C., Alt, I., Rohrer, F., Fuchs, E., Vilagos, B., Krall, N., Christoph, M., Schumacher, M., Maurer, D., Hackner, K., Lafleur, J., Hefler, L., Fureder, T. & Vladimer, G. I., 2020, In: Cancer Research. 80, 16 Supplement, p. 5233 1 p.

  Research output: Journal article (peer-reviewed) › Conference contribution to journal

  Open Access

  • Drug Mechanism 100%
  • Drug Action 100%
  • Malignant Pleura Effusion 100%
  • Drug Activity 60%
  • Cancer Cell 40%

• Chronic thromboembolic pulmonary hypertension: improvement of sleep-disordered breathing after balloon pulmonary angioplasty

  Hackner, K., Maurer, M., Gerges, C., Gerges, M., Kneussl, M., Errhalt, P., Javaheri, S. & Lang, I., 15 Sept 2020, In: Journal of Sleep Research. 29, p. e13181

  Research output: Journal article (peer-reviewed) › Conference contribution to journal

  Open Access
  1 Citation (Scopus)

• Combined targeting of distinct c-Myc and JunB transcriptional programs for multiple myeloma therapy: Abstractband für die Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020: Abstracts

  Lind, J., Czernilofsky, F., Vallet, S., Fan, F., Bakiri, L., Wagner, E. F., Sattler, M., Pecherstorfer, M. & Podar, K., 2020, In: Oncology Research and Treatment. 43, Suppl. 4, p. 92

  Research output: Journal article (peer-reviewed) › Conference contribution to journal

  Open Access

• Immunophenotyping of Baseline Bone Marrow Reveals a Specific Pattern of Immune Cells Associated with Greater Depth and Sustained Response in Newly Diagnosed Patients Randomized to Krd or Ktd Followed By Carfilzomib Maintenance or Control (AGMT MM 02 Study)

  Manrique, I., Greil, R., Andel, J., Sormann, S., Hartmann, B. L., Podar, K., Egle, A., Petzer, A., Zojer, N., Ruckser, R., Bozic, B., Schmitt, C. A., Machherndl-Spandl, S., Agis, H., Schreder, M., Krauth, M.-T., Tinchon, C., Fillitz, M., Melchardt, T. & Paiva, B. & 1 others, Ludwig, H., 2020, In: Blood. 136, Supplement 1, p. 29-30 2 p.

  Research output: Journal article (peer-reviewed) › Conference contribution to journal

  • Natural Killer Cell 100%
  • Immunocompetent Cell 100%
  • Immunophenotyping 100%
  • Immunity 100%
  • Bone Marrow 100%

• Quality of Life in Newly Diagnosed Patients with Multiple Myeloma Randomized to Either Krd or Ktd Induction Therapy Followed By Carfilzomib Maintenance or Control (AGMT MM 02 trial)

  Ludwig, H., Melchardt, T., Andel, J., Gunsilius, E., Sormann, S., Hinke, A., Hartmann, B. L., Podar, K., Willenbacher, W., Egle, A., Petzer, A., Zojer, N., Wöll, E., Ruckser, R., Bozic, B., Schmitt, C. A., Machherndl-Spandl, S., Krauth, M.-T., Schreder, M. & Agis, H. & 3 others, Tinchon, C., Fillitz, M. & Greil, R., 2020, In: Blood. 136, Supplement 1, p. 27-29 3 p.

  Research output: Journal article (peer-reviewed) › Conference contribution to journal

  • Multiple Myeloma 100%
  • Carfilzomib 100%
  • Quality of Life 100%
  • Population 75%
  • Maintenance Therapy 25%

• Towards patient-centric drug discovery: Drug action in malignant pleural effusions and ascites using high content imaging and deep learning.

  Krall, N., Sehlke, R., Taubert, C., Alt, I., Rohrer, F., Fuchs, E., Vilagos, B., Schumacher, M., Maurer, D., Hackner, K., Lafleur, J., Hefler, L., Minichsdorfer, C., Fuereder, T. & Vladimer, G. I., 20 May 2020, In: Journal of Clinical Oncology. p. e21633-e21633

  Research output: Journal article (peer-reviewed) › Conference contribution to journal
• 2019

  Carfilzomib-Revlimid-Dexamethasone Vs. Carfilzomib-Thalidomide-Dexamethasone Weekly (After 2 Twice Weekly Cycles) Followed By Carfilzomib Maintenance Vs. Control in Transplant Non-Eligible Patients with Newly Diagnosed Multiple Myeloma (NDMM) - Interim Efficacy Analysis of Combined Data (AGMT MM-02): American Society of Hematology, 61th Annual Meeting, scientific session

  Ludwig, H., Sormann, S., Zojer, N., Andel, J., Hartmann, B. L., Tinchon, C., Gunsilius, E., Podar, K., Egle, A., Willenbacher, W., Wöll, E., Ruckser, R., Bozic, B., Krauth, M.-T., Petzer, A., Schmitt, C. A., Machherndl-Spandl, S., Agis, H., Paiva, B. & Greil, R., 2019, In: Blood. 134, Supplement_1, p. 696 1 p.

  Research output: Journal article (peer-reviewed) › Conference contribution to journal

  • Americans 100%
  • Annuals 100%
  • Dexamethasone 100%
  • Cytogenetics 33%
  • Population 20%

• Combined Targeting of Distinct c-Myc and JunB Transcriptional Programs for Multiple Myelioma Therapy: American Society of Hematology, 61th Annual Meeting, scientific session

  Lind, J., Czernilofsky, F., Vallet, S., Fan, F., Sattler, M., Bakiri, L., Wagner, E. F., Percherstorfer, M. & Podar, K., 2019, In: Blood. 134, Supplement_1, p. 4415 1 p.

  Research output: Journal article (peer-reviewed) › Conference contribution to journal

  • Myc Protein 100%
  • Ligase 50%
  • G1/S Transition 50%
  • Doxycycline 45%

• Expanding on Current Definitions of Hematologic Improvement in MDS, CMML and AML: Landmark Analyses of 1301 Patients Treated with Azacitidine in the Austrian Registry of Hypomethylating Agents By the AGMT-Study Group: American Society of Hematology, 61th Annual Meeting, scientific session

  Pleyer, L., Pfeilstocker, M., Stauder, R., Heibl, S., Sill, H., Girschikofsky, M., Stampfl-Mattersberger, M., Tinchon, C., Petzer, A., Schmitt, C. A., Vallet, S., Mandac, I., Geissler, K., Sperr, W. R., Leisch, M., Egle, A., Melchardt, T., Fusinato, J., Piringer, G. & Zebisch, A. & 4 others, Machherndl-Spandl, S., Wolf, D., Keil, F. & Greil, R., 2019, In: Blood. 134, Supplement_1, p. 3821 1 p.

  Research output: Journal article (peer-reviewed) › Conference contribution to journal

  • Acute Myeloid Leukemia 100%
  • Myelodysplastic Syndrome 100%
  • Azacitidine 100%
  • Hypomethylating Agent 100%
  • Chronic Myelomonocytic Leukemia 100%

• Multiple Myeloma Pathogenesis: The Role of Junb in Bone Marrow Angiogenesis: American Society of Hematology, 61th Annual Meeting, scientific session

  Fan, F., Malvestiti, S., Shen, Y., Morelli, E., Mishima, Y., Seckinger, A., Hose, D., Bakiri, L., Vallet, S., Sattler, M., Roccaro, A. M., Goldschmidt, H., Percherstorfer, M., Sun, C., Hu, Y., Wagner, E. F., Tassone, P., Ghobrial, I. M., Jaeger, D. & Podar, K., 2019, In: Blood. 134, Supplement_1, p. 4341 1 p.

  Research output: Journal article (peer-reviewed) › Conference contribution to journal

  • Angiogenesis 100%
  • Cell Clone 33%
  • TetR 23%
  • Angiogenic Factor 16%
  • Chromatin Immunoprecipitation 16%